Share Facebook Twitter LinkedIn Pinterest Email Ionis Prescribed drugs, Inc. (IONS) Discusses Detailed Part III Outcomes for Olezarsen in Extreme Hypertriglyceridemia – SlideshowLike this:Like Loading...Related detailed discusses Hypertriglyceridemia III Ionis IONS Olezarsen Pharmaceuticals phase Results severe Slideshow